nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—DRD3—Parkinson's disease	0.168	0.222	CbGaD
Lisuride—DRD1—Parkinson's disease	0.165	0.218	CbGaD
Lisuride—HTR1A—Parkinson's disease	0.137	0.181	CbGaD
Lisuride—DRD2—Parkinson's disease	0.117	0.153	CbGaD
Lisuride—HTR2A—Parkinson's disease	0.09	0.119	CbGaD
Lisuride—CYP2D6—Parkinson's disease	0.0823	0.108	CbGaD
Lisuride—DRD3—telencephalic ventricle—Parkinson's disease	0.00397	0.0479	CbGeAlD
Lisuride—HTR2A—enteric nervous system—Parkinson's disease	0.00354	0.0427	CbGeAlD
Lisuride—DRD1—telencephalic ventricle—Parkinson's disease	0.00285	0.0343	CbGeAlD
Lisuride—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00268	0.0324	CbGeAlD
Lisuride—HTR2A—locus ceruleus—Parkinson's disease	0.00234	0.0282	CbGeAlD
Lisuride—HTR1B—telencephalic ventricle—Parkinson's disease	0.00231	0.0278	CbGeAlD
Lisuride—HTR1D—telencephalic ventricle—Parkinson's disease	0.00223	0.0269	CbGeAlD
Lisuride—HTR2C—telencephalic ventricle—Parkinson's disease	0.00221	0.0267	CbGeAlD
Lisuride—HTR2A—cerebellar cortex—Parkinson's disease	0.00191	0.023	CbGeAlD
Lisuride—HTR1A—telencephalic ventricle—Parkinson's disease	0.00186	0.0225	CbGeAlD
Lisuride—HTR2A—sympathetic nervous system—Parkinson's disease	0.00185	0.0223	CbGeAlD
Lisuride—DRD1—nerve—Parkinson's disease	0.00179	0.0216	CbGeAlD
Lisuride—DRD2—telencephalic ventricle—Parkinson's disease	0.00168	0.0203	CbGeAlD
Lisuride—HTR2A—pons—Parkinson's disease	0.00135	0.0163	CbGeAlD
Lisuride—HTR2A—autonomic nervous system—Parkinson's disease	0.00124	0.015	CbGeAlD
Lisuride—HTR2A—telencephalic ventricle—Parkinson's disease	0.00111	0.0134	CbGeAlD
Lisuride—DRD2—nerve—Parkinson's disease	0.00106	0.0128	CbGeAlD
Lisuride—ADRA2A—peripheral nervous system—Parkinson's disease	0.00105	0.0127	CbGeAlD
Lisuride—DRD5—forebrain—Parkinson's disease	0.000973	0.0117	CbGeAlD
Lisuride—HTR2A—peripheral nervous system—Parkinson's disease	0.000897	0.0108	CbGeAlD
Lisuride—HTR1A—hindbrain—Parkinson's disease	0.000879	0.0106	CbGeAlD
Lisuride—DRD2—hindbrain—Parkinson's disease	0.000794	0.00958	CbGeAlD
Lisuride—ADRA1D—forebrain—Parkinson's disease	0.00078	0.00941	CbGeAlD
Lisuride—DRD1—brainstem—Parkinson's disease	0.00077	0.00929	CbGeAlD
Lisuride—DRD1—forebrain—Parkinson's disease	0.000743	0.00897	CbGeAlD
Lisuride—HTR2A—nerve—Parkinson's disease	0.000699	0.00843	CbGeAlD
Lisuride—HTR1B—brainstem—Parkinson's disease	0.000624	0.00753	CbGeAlD
Lisuride—DRD4—brain—Parkinson's disease	0.000613	0.00739	CbGeAlD
Lisuride—HTR1D—brainstem—Parkinson's disease	0.000604	0.00729	CbGeAlD
Lisuride—HTR1B—forebrain—Parkinson's disease	0.000602	0.00726	CbGeAlD
Lisuride—HTR2C—brainstem—Parkinson's disease	0.000598	0.00722	CbGeAlD
Lisuride—DRD3—head—Parkinson's disease	0.000594	0.00717	CbGeAlD
Lisuride—HTR1D—forebrain—Parkinson's disease	0.000583	0.00703	CbGeAlD
Lisuride—HTR2C—forebrain—Parkinson's disease	0.000577	0.00697	CbGeAlD
Lisuride—ADRB1—forebrain—Parkinson's disease	0.000567	0.00683	CbGeAlD
Lisuride—DRD3—nervous system—Parkinson's disease	0.000563	0.0068	CbGeAlD
Lisuride—DRD5—head—Parkinson's disease	0.000557	0.00672	CbGeAlD
Lisuride—Cabergoline—HTR7—Parkinson's disease	0.00055	0.0757	CrCbGaD
Lisuride—DRD3—central nervous system—Parkinson's disease	0.000542	0.00654	CbGeAlD
Lisuride—HTR2B—forebrain—Parkinson's disease	0.000542	0.00654	CbGeAlD
Lisuride—DRD5—nervous system—Parkinson's disease	0.000528	0.00637	CbGeAlD
Lisuride—HTR2A—hindbrain—Parkinson's disease	0.000524	0.00632	CbGeAlD
Lisuride—Cabergoline—DRD3—Parkinson's disease	0.000517	0.0712	CrCbGaD
Lisuride—HTR1B—cardiovascular system—Parkinson's disease	0.000509	0.00614	CbGeAlD
Lisuride—DRD5—central nervous system—Parkinson's disease	0.000508	0.00613	CbGeAlD
Lisuride—Cabergoline—DRD1—Parkinson's disease	0.000508	0.0699	CrCbGaD
Lisuride—Methylergometrine—DRD1—Parkinson's disease	0.000508	0.0699	CrCbGaD
Lisuride—HTR1A—brainstem—Parkinson's disease	0.000504	0.00607	CbGeAlD
Lisuride—HTR1D—cardiovascular system—Parkinson's disease	0.000493	0.00595	CbGeAlD
Lisuride—DRD1—midbrain—Parkinson's disease	0.000491	0.00592	CbGeAlD
Lisuride—HTR1A—forebrain—Parkinson's disease	0.000486	0.00586	CbGeAlD
Lisuride—ADRB1—cardiovascular system—Parkinson's disease	0.000479	0.00578	CbGeAlD
Lisuride—CYP2D6—hindbrain—Parkinson's disease	0.000477	0.00575	CbGeAlD
Lisuride—Methysergide—HTR7—Parkinson's disease	0.000459	0.0632	CrCbGaD
Lisuride—HTR2B—cardiovascular system—Parkinson's disease	0.000459	0.00553	CbGeAlD
Lisuride—ADRA1B—head—Parkinson's disease	0.000457	0.00551	CbGeAlD
Lisuride—DRD2—brainstem—Parkinson's disease	0.000455	0.00549	CbGeAlD
Lisuride—ADRA1D—head—Parkinson's disease	0.000447	0.00539	CbGeAlD
Lisuride—DRD2—forebrain—Parkinson's disease	0.000439	0.0053	CbGeAlD
Lisuride—ADRA1B—nervous system—Parkinson's disease	0.000433	0.00522	CbGeAlD
Lisuride—DRD3—brain—Parkinson's disease	0.000431	0.0052	CbGeAlD
Lisuride—DRD1—head—Parkinson's disease	0.000426	0.00513	CbGeAlD
Lisuride—ADRA1D—nervous system—Parkinson's disease	0.000423	0.00511	CbGeAlD
Lisuride—Cabergoline—HTR1A—Parkinson's disease	0.000422	0.058	CrCbGaD
Lisuride—HTR2C—medulla oblongata—Parkinson's disease	0.000417	0.00503	CbGeAlD
Lisuride—ADRA1B—central nervous system—Parkinson's disease	0.000417	0.00503	CbGeAlD
Lisuride—HTR1A—cardiovascular system—Parkinson's disease	0.000411	0.00496	CbGeAlD
Lisuride—ADRA1D—central nervous system—Parkinson's disease	0.000408	0.00492	CbGeAlD
Lisuride—DRD5—brain—Parkinson's disease	0.000404	0.00487	CbGeAlD
Lisuride—DRD1—nervous system—Parkinson's disease	0.000403	0.00487	CbGeAlD
Lisuride—Pergolide—DRD3—Parkinson's disease	0.0004	0.055	CrCbGaD
Lisuride—HTR1B—midbrain—Parkinson's disease	0.000398	0.0048	CbGeAlD
Lisuride—Pergolide—DRD1—Parkinson's disease	0.000392	0.054	CrCbGaD
Lisuride—DRD1—central nervous system—Parkinson's disease	0.000388	0.00469	CbGeAlD
Lisuride—HTR1B—spinal cord—Parkinson's disease	0.000388	0.00468	CbGeAlD
Lisuride—HTR1D—midbrain—Parkinson's disease	0.000385	0.00464	CbGeAlD
Lisuride—HTR2C—midbrain—Parkinson's disease	0.000381	0.0046	CbGeAlD
Lisuride—HTR2C—spinal cord—Parkinson's disease	0.000372	0.00449	CbGeAlD
Lisuride—Cabergoline—DRD2—Parkinson's disease	0.000358	0.0493	CrCbGaD
Lisuride—Methysergide—HTR1A—Parkinson's disease	0.000352	0.0484	CrCbGaD
Lisuride—HTR1B—head—Parkinson's disease	0.000345	0.00416	CbGeAlD
Lisuride—ADRA2A—forebrain—Parkinson's disease	0.000341	0.00411	CbGeAlD
Lisuride—HTR1D—head—Parkinson's disease	0.000334	0.00403	CbGeAlD
Lisuride—ADRA1B—brain—Parkinson's disease	0.000331	0.00399	CbGeAlD
Lisuride—HTR2C—head—Parkinson's disease	0.000331	0.00399	CbGeAlD
Lisuride—HTR2A—embryo—Parkinson's disease	0.000327	0.00395	CbGeAlD
Lisuride—HTR1B—nervous system—Parkinson's disease	0.000327	0.00394	CbGeAlD
Lisuride—Pergolide—HTR1A—Parkinson's disease	0.000326	0.0449	CrCbGaD
Lisuride—ADRB1—head—Parkinson's disease	0.000324	0.00391	CbGeAlD
Lisuride—ADRA1D—brain—Parkinson's disease	0.000324	0.0039	CbGeAlD
Lisuride—HTR1A—midbrain—Parkinson's disease	0.000321	0.00387	CbGeAlD
Lisuride—HTR1D—nervous system—Parkinson's disease	0.000316	0.00382	CbGeAlD
Lisuride—HTR1B—central nervous system—Parkinson's disease	0.000315	0.0038	CbGeAlD
Lisuride—HTR2C—nervous system—Parkinson's disease	0.000313	0.00378	CbGeAlD
Lisuride—HTR1A—spinal cord—Parkinson's disease	0.000313	0.00378	CbGeAlD
Lisuride—HTR2B—head—Parkinson's disease	0.000311	0.00375	CbGeAlD
Lisuride—ADRA2C—medulla oblongata—Parkinson's disease	0.000308	0.00372	CbGeAlD
Lisuride—DRD1—brain—Parkinson's disease	0.000308	0.00372	CbGeAlD
Lisuride—ADRB1—nervous system—Parkinson's disease	0.000308	0.00371	CbGeAlD
Lisuride—HTR1D—central nervous system—Parkinson's disease	0.000305	0.00368	CbGeAlD
Lisuride—HTR2C—central nervous system—Parkinson's disease	0.000302	0.00364	CbGeAlD
Lisuride—HTR2A—brainstem—Parkinson's disease	0.0003	0.00362	CbGeAlD
Lisuride—ADRB1—central nervous system—Parkinson's disease	0.000296	0.00357	CbGeAlD
Lisuride—HTR2B—nervous system—Parkinson's disease	0.000294	0.00355	CbGeAlD
Lisuride—DRD2—midbrain—Parkinson's disease	0.00029	0.0035	CbGeAlD
Lisuride—HTR2A—forebrain—Parkinson's disease	0.00029	0.00349	CbGeAlD
Lisuride—HTR2B—central nervous system—Parkinson's disease	0.000283	0.00342	CbGeAlD
Lisuride—ADRA2C—midbrain—Parkinson's disease	0.000282	0.0034	CbGeAlD
Lisuride—HTR1A—head—Parkinson's disease	0.000278	0.00336	CbGeAlD
Lisuride—Pergolide—DRD2—Parkinson's disease	0.000277	0.0381	CrCbGaD
Lisuride—Methylergometrine—HTR2A—Parkinson's disease	0.000277	0.0381	CrCbGaD
Lisuride—Cabergoline—HTR2A—Parkinson's disease	0.000277	0.0381	CrCbGaD
Lisuride—ADRA2C—spinal cord—Parkinson's disease	0.000275	0.00332	CbGeAlD
Lisuride—CYP2D6—brainstem—Parkinson's disease	0.000273	0.0033	CbGeAlD
Lisuride—Ergotamine—HTR1A—Parkinson's disease	0.000272	0.0374	CrCbGaD
Lisuride—CYP2D6—forebrain—Parkinson's disease	0.000264	0.00318	CbGeAlD
Lisuride—HTR1A—nervous system—Parkinson's disease	0.000264	0.00318	CbGeAlD
Lisuride—HTR1A—central nervous system—Parkinson's disease	0.000254	0.00306	CbGeAlD
Lisuride—DRD2—head—Parkinson's disease	0.000251	0.00303	CbGeAlD
Lisuride—HTR1B—brain—Parkinson's disease	0.00025	0.00301	CbGeAlD
Lisuride—HTR1A—cerebellum—Parkinson's disease	0.000248	0.00299	CbGeAlD
Lisuride—ADRA2A—medulla oblongata—Parkinson's disease	0.000246	0.00297	CbGeAlD
Lisuride—HTR2A—cardiovascular system—Parkinson's disease	0.000245	0.00295	CbGeAlD
Lisuride—ADRA2C—head—Parkinson's disease	0.000244	0.00295	CbGeAlD
Lisuride—HTR1D—brain—Parkinson's disease	0.000242	0.00292	CbGeAlD
Lisuride—HTR2C—brain—Parkinson's disease	0.00024	0.00289	CbGeAlD
Lisuride—DRD2—nervous system—Parkinson's disease	0.000238	0.00288	CbGeAlD
Lisuride—ADRB1—brain—Parkinson's disease	0.000235	0.00284	CbGeAlD
Lisuride—ADRA2C—nervous system—Parkinson's disease	0.000232	0.0028	CbGeAlD
Lisuride—Methysergide—HTR2A—Parkinson's disease	0.000231	0.0318	CrCbGaD
Lisuride—Ergotamine—DRD2—Parkinson's disease	0.000231	0.0318	CrCbGaD
Lisuride—DRD2—central nervous system—Parkinson's disease	0.000229	0.00277	CbGeAlD
Lisuride—HTR2B—brain—Parkinson's disease	0.000225	0.00271	CbGeAlD
Lisuride—ADRA2A—midbrain—Parkinson's disease	0.000225	0.00271	CbGeAlD
Lisuride—DRD2—cerebellum—Parkinson's disease	0.000224	0.00271	CbGeAlD
Lisuride—ADRA2C—central nervous system—Parkinson's disease	0.000223	0.00269	CbGeAlD
Lisuride—ADRA2A—spinal cord—Parkinson's disease	0.000219	0.00265	CbGeAlD
Lisuride—ADRA2C—cerebellum—Parkinson's disease	0.000218	0.00263	CbGeAlD
Lisuride—Pergolide—HTR2A—Parkinson's disease	0.000214	0.0294	CrCbGaD
Lisuride—HTR2A—medulla oblongata—Parkinson's disease	0.000209	0.00252	CbGeAlD
Lisuride—Ergonovine—ABCB1—Parkinson's disease	0.000207	0.0284	CrCbGaD
Lisuride—HTR1A—brain—Parkinson's disease	0.000202	0.00243	CbGeAlD
Lisuride—Pergolide—CYP2D6—Parkinson's disease	0.000195	0.0269	CrCbGaD
Lisuride—ADRA2A—head—Parkinson's disease	0.000195	0.00235	CbGeAlD
Lisuride—HTR2A—midbrain—Parkinson's disease	0.000191	0.00231	CbGeAlD
Lisuride—HTR2A—spinal cord—Parkinson's disease	0.000187	0.00225	CbGeAlD
Lisuride—ADRA2A—nervous system—Parkinson's disease	0.000185	0.00223	CbGeAlD
Lisuride—DRD2—brain—Parkinson's disease	0.000182	0.0022	CbGeAlD
Lisuride—Ergotamine—HTR2A—Parkinson's disease	0.000178	0.0245	CrCbGaD
Lisuride—ADRA2A—central nervous system—Parkinson's disease	0.000178	0.00215	CbGeAlD
Lisuride—ADRA2C—brain—Parkinson's disease	0.000177	0.00214	CbGeAlD
Lisuride—ADRA2A—cerebellum—Parkinson's disease	0.000174	0.0021	CbGeAlD
Lisuride—HTR2A—head—Parkinson's disease	0.000166	0.002	CbGeAlD
Lisuride—HTR2A—nervous system—Parkinson's disease	0.000157	0.0019	CbGeAlD
Lisuride—HTR2A—central nervous system—Parkinson's disease	0.000151	0.00183	CbGeAlD
Lisuride—CYP2D6—head—Parkinson's disease	0.000151	0.00182	CbGeAlD
Lisuride—HTR2A—cerebellum—Parkinson's disease	0.000148	0.00178	CbGeAlD
Lisuride—CYP3A4—nervous system—Parkinson's disease	0.000146	0.00176	CbGeAlD
Lisuride—CYP2D6—nervous system—Parkinson's disease	0.000143	0.00173	CbGeAlD
Lisuride—ADRA2A—brain—Parkinson's disease	0.000141	0.00171	CbGeAlD
Lisuride—CYP3A4—central nervous system—Parkinson's disease	0.00014	0.00169	CbGeAlD
Lisuride—CYP2D6—central nervous system—Parkinson's disease	0.000138	0.00166	CbGeAlD
Lisuride—CYP2D6—cerebellum—Parkinson's disease	0.000135	0.00163	CbGeAlD
Lisuride—HTR2A—brain—Parkinson's disease	0.00012	0.00145	CbGeAlD
Lisuride—Ergotamine—ABCB1—Parkinson's disease	0.000116	0.016	CrCbGaD
Lisuride—CYP2D6—brain—Parkinson's disease	0.000109	0.00132	CbGeAlD
Lisuride—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	7.62e-06	5.08e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	7.62e-06	5.07e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NGF—Parkinson's disease	7.61e-06	5.07e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	7.61e-06	5.07e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	7.59e-06	5.05e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—HMOX1—Parkinson's disease	7.58e-06	5.05e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	7.57e-06	5.04e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF2—Parkinson's disease	7.52e-06	5.01e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—INS—Parkinson's disease	7.51e-06	5e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—DRD3—Parkinson's disease	7.49e-06	4.99e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—NQO1—Parkinson's disease	7.49e-06	4.99e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	7.47e-06	4.97e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	7.47e-06	4.97e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NGF—Parkinson's disease	7.45e-06	4.96e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	7.42e-06	4.94e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF2—Parkinson's disease	7.42e-06	4.94e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—TH—Parkinson's disease	7.38e-06	4.91e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	7.37e-06	4.91e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	7.35e-06	4.89e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	7.35e-06	4.89e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	7.33e-06	4.88e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NGF—Parkinson's disease	7.33e-06	4.88e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ABCB1—Parkinson's disease	7.28e-06	4.85e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	7.27e-06	4.84e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.26e-06	4.83e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	7.24e-06	4.82e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	7.21e-06	4.8e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	7.19e-06	4.79e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EDN1—Parkinson's disease	7.18e-06	4.78e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	7.17e-06	4.78e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	7.17e-06	4.78e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	7.17e-06	4.77e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	7.09e-06	4.72e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	7.09e-06	4.72e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EDN1—Parkinson's disease	7.09e-06	4.72e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CYCS—Parkinson's disease	7.09e-06	4.72e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GSTM1—Parkinson's disease	7.07e-06	4.71e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	7.06e-06	4.7e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NGF—Parkinson's disease	7e-06	4.66e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	6.99e-06	4.66e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	6.98e-06	4.65e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	6.92e-06	4.61e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.88e-06	4.58e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HTR7—Parkinson's disease	6.77e-06	4.51e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GPX1—Parkinson's disease	6.77e-06	4.51e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	6.76e-06	4.5e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—APOE—Parkinson's disease	6.74e-06	4.49e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	6.71e-06	4.47e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	6.7e-06	4.46e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	6.67e-06	4.44e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	6.67e-06	4.44e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	6.66e-06	4.44e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NGF—Parkinson's disease	6.6e-06	4.4e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—APOE—Parkinson's disease	6.59e-06	4.39e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	6.54e-06	4.35e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	6.51e-06	4.34e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NGF—Parkinson's disease	6.51e-06	4.34e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—APOE—Parkinson's disease	6.49e-06	4.32e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	6.48e-06	4.31e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	6.47e-06	4.31e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	6.46e-06	4.3e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	6.43e-06	4.28e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	6.4e-06	4.26e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	6.28e-06	4.18e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—COMT—Parkinson's disease	6.28e-06	4.18e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.26e-06	4.17e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	6.26e-06	4.17e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	6.25e-06	4.16e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GSTP1—Parkinson's disease	6.25e-06	4.16e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—MTHFR—Parkinson's disease	6.24e-06	4.16e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—MAOA—Parkinson's disease	6.23e-06	4.15e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	6.22e-06	4.14e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	6.2e-06	4.13e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	6.2e-06	4.13e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—APOE—Parkinson's disease	6.19e-06	4.13e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	6.18e-06	4.11e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—HMOX1—Parkinson's disease	6.16e-06	4.1e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	6.16e-06	4.1e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	6.15e-06	4.09e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	6.06e-06	4.04e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	6.06e-06	4.04e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	6.05e-06	4.03e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	5.98e-06	3.98e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	5.95e-06	3.96e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NGF—Parkinson's disease	5.93e-06	3.95e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ABCB1—Parkinson's disease	5.91e-06	3.94e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	5.88e-06	3.92e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	5.88e-06	3.92e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—APOE—Parkinson's disease	5.84e-06	3.89e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—APOE—Parkinson's disease	5.81e-06	3.87e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	5.76e-06	3.84e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—APOE—Parkinson's disease	5.76e-06	3.84e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—INS—Parkinson's disease	5.75e-06	3.83e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GSTM1—Parkinson's disease	5.74e-06	3.82e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF2—Parkinson's disease	5.68e-06	3.78e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NGF—Parkinson's disease	5.68e-06	3.78e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	5.65e-06	3.76e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NGF—Parkinson's disease	5.65e-06	3.76e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—DDC—Parkinson's disease	5.64e-06	3.76e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—INS—Parkinson's disease	5.63e-06	3.75e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	5.6e-06	3.73e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CASP3—Parkinson's disease	5.59e-06	3.72e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	5.59e-06	3.72e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—Parkinson's disease	5.56e-06	3.7e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—INS—Parkinson's disease	5.54e-06	3.69e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GPX1—Parkinson's disease	5.5e-06	3.66e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	5.49e-06	3.66e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	5.49e-06	3.66e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EDN1—Parkinson's disease	5.42e-06	3.61e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	5.41e-06	3.6e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	5.4e-06	3.6e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	5.4e-06	3.6e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	5.38e-06	3.58e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	5.34e-06	3.55e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.33e-06	3.55e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.3e-06	3.53e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—INS—Parkinson's disease	5.29e-06	3.52e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—APOE—Parkinson's disease	5.25e-06	3.5e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	5.23e-06	3.48e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	5.2e-06	3.47e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	5.15e-06	3.43e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	5.14e-06	3.42e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	5.08e-06	3.38e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—MTHFR—Parkinson's disease	5.07e-06	3.38e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.02e-06	3.35e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5e-06	3.33e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—INS—Parkinson's disease	4.99e-06	3.32e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NGF—Parkinson's disease	4.98e-06	3.32e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—INS—Parkinson's disease	4.97e-06	3.31e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.93e-06	3.29e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—INS—Parkinson's disease	4.92e-06	3.28e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—INS—Parkinson's disease	4.92e-06	3.28e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	4.91e-06	3.27e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NGF—Parkinson's disease	4.9e-06	3.27e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.88e-06	3.25e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	4.86e-06	3.24e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	4.85e-06	3.23e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—TH—Parkinson's disease	4.81e-06	3.2e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.79e-06	3.19e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	4.78e-06	3.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.75e-06	3.16e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.74e-06	3.16e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—APOE—Parkinson's disease	4.72e-06	3.14e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.62e-06	3.07e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—INS—Parkinson's disease	4.49e-06	2.99e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	4.46e-06	2.97e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—INS—Parkinson's disease	4.45e-06	2.96e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOE—Parkinson's disease	4.41e-06	2.94e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.34e-06	2.89e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.29e-06	2.86e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	4.28e-06	2.85e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.27e-06	2.84e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	4.26e-06	2.83e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	4.25e-06	2.83e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	4.19e-06	2.79e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	4.17e-06	2.78e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—INS—Parkinson's disease	4.15e-06	2.77e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CASP3—Parkinson's disease	4.13e-06	2.75e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—Parkinson's disease	4.1e-06	2.73e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—COMT—Parkinson's disease	4.09e-06	2.72e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.09e-06	2.72e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.07e-06	2.71e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.06e-06	2.7e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—INS—Parkinson's disease	4.03e-06	2.69e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.01e-06	2.67e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	3.95e-06	2.63e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	3.94e-06	2.62e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	3.94e-06	2.62e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	3.91e-06	2.61e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	3.86e-06	2.57e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.85e-06	2.57e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	3.79e-06	2.53e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—INS—Parkinson's disease	3.77e-06	2.51e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.74e-06	2.49e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CASP3—Parkinson's disease	3.72e-06	2.47e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.71e-06	2.47e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—Parkinson's disease	3.69e-06	2.46e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	2.44e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	2.44e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	3.64e-06	2.43e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—Parkinson's disease	3.64e-06	2.43e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	3.62e-06	2.41e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.58e-06	2.39e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.53e-06	2.35e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.46e-06	2.31e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	3.42e-06	2.27e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3.37e-06	2.25e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	2.24e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	2.24e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	3.34e-06	2.22e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	3.32e-06	2.21e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.31e-06	2.2e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.31e-06	2.2e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.29e-06	2.19e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—Parkinson's disease	3.28e-06	2.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.23e-06	2.15e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.2e-06	2.13e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.19e-06	2.12e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.18e-06	2.12e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.17e-06	2.11e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.16e-06	2.1e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TH—Parkinson's disease	3.14e-06	2.09e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	3.09e-06	2.06e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—Parkinson's disease	3.08e-06	2.05e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	3.07e-06	2.05e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	3.07e-06	2.04e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.04e-06	2.03e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.04e-06	2.03e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.02e-06	2.01e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.02e-06	2.01e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.94e-06	1.96e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.92e-06	1.95e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.84e-06	1.89e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.81e-06	1.87e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.8e-06	1.86e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.79e-06	1.86e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.76e-06	1.84e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.74e-06	1.83e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—COMT—Parkinson's disease	2.67e-06	1.78e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.66e-06	1.77e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.65e-06	1.77e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—INS—Parkinson's disease	2.63e-06	1.75e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.62e-06	1.75e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.58e-06	1.72e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.54e-06	1.69e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.52e-06	1.68e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.51e-06	1.67e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.51e-06	1.67e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.5e-06	1.66e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.46e-06	1.64e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.45e-06	1.63e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—Parkinson's disease	2.42e-06	1.61e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.34e-06	1.56e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.31e-06	1.54e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.31e-06	1.54e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—Parkinson's disease	2.18e-06	1.45e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.16e-06	1.44e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	1.43e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	1.43e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—Parkinson's disease	2.01e-06	1.34e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.96e-06	1.31e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.94e-06	1.29e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.88e-06	1.25e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.87e-06	1.24e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.81e-06	1.21e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.79e-06	1.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—INS—Parkinson's disease	1.72e-06	1.14e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.65e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.62e-06	1.08e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.47e-06	9.82e-06	CbGpPWpGaD
